These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8731308)

  • 1. [Morphologic aspects of the left ventricular remodeling in hypertensive cardiomyopathy].
    Mandarim-de-Lacerda CA
    Arq Bras Cardiol; 1995 Dec; 65(6):523-7. PubMed ID: 8731308
    [No Abstract]   [Full Text] [Related]  

  • 2. Images in cardiovascular medicine. Diagnostic utility of cardiac magnetic resonance imaging in monozygotic twins with hypertrophic cardiomyopathy and identical pattern of left ventricular hypertrophy.
    Maron BJ; Haas TS; Lesser JR
    Circulation; 2007 Jun; 115(24):e627-8. PubMed ID: 17576874
    [No Abstract]   [Full Text] [Related]  

  • 3. Pathological versus physiological left ventricular hypertrophy: a review.
    Richey PA; Brown SP
    J Sports Sci; 1998 Feb; 16(2):129-41. PubMed ID: 9531002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Impact of arterial hypertension on the heart].
    Herpin D
    Rev Prat; 1999 Mar; 49(5):491-4. PubMed ID: 10358398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel hypertrophic cardiomyopathy phenotype: segmental hypertrophy isolated to the posterobasal left ventricular free wall.
    Maron BJ; Sherrid MV; Haas TS; Lindberg J; Kitner C; Lesser JR
    Am J Cardiol; 2010 Sep; 106(5):750-2. PubMed ID: 20723657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Left ventricular involvement in right ventricular dysplasia/cardiomyopathy.
    Lobo FV; Silver MD; Butany J; Heggtveit HA
    Can J Cardiol; 1999 Nov; 15(11):1239-47. PubMed ID: 10579739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired response of left ventricular relaxation to exercise-induced adrenergic stimulation in patients with hypertrophic cardiomyopathy.
    Izawa H; Yokota M; Nagata K; Iwase M; Sobue T
    J Am Coll Cardiol; 1996 Dec; 28(7):1738-45. PubMed ID: 8962560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different pathophysiology of cardiac hypertrophy in hypertension and hypertrophic cardiomyopathy.
    Takeda A; Takeda N
    J Mol Cell Cardiol; 1997 Nov; 29(11):2961-5. PubMed ID: 9405171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apical aneurysm and left ventricular hypertrophy.
    Soufen HN; Frimm Cd; Benvenuti LA; Mady C
    Arq Bras Cardiol; 2000 Aug; 75(2):145-50. PubMed ID: 10983031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ventricular arrhythmias in myocardial hypertrophy of various origins.
    Spacek R; Gregor P
    Can J Cardiol; 1997 May; 13(5):455-8. PubMed ID: 9179083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical significance of late gadolinium enhancement on cardiovascular magnetic resonance in patients with hypertrophic cardiomyopathy].
    Dumont CA; Monserrat L; Soler R; Rodríguez E; Fernández X; Peteiro J; Bouzas B; Piñón P; Castro-Beiras A
    Rev Esp Cardiol; 2007 Jan; 60(1):15-23. PubMed ID: 17288951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Variants of heart remodeling in essential hypertension: prevalence and determinants].
    Konradi AO; Rudomanov OG; Zakharov DV; Vakhrameeva NV; Krutikov AN; Iakovleva OI; Shliakhto EV
    Ter Arkh; 2005; 77(9):8-16. PubMed ID: 16281481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is Regression of Left Ventricular Hypertrophy Really a Good Thing for Patients With Hypertrophic Cardiomyopathy?: The Emerging Mavacamten Story.
    Maron BJ; Rowin EJ; Maron MS
    Am J Cardiol; 2021 May; 147():145-146. PubMed ID: 33549527
    [No Abstract]   [Full Text] [Related]  

  • 14. [Ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy].
    Cecchi F
    Ital Heart J Suppl; 2000 Dec; 1(12):1648-9. PubMed ID: 11221596
    [No Abstract]   [Full Text] [Related]  

  • 15. Extracellular matrix remodeling in hypertensive heart disease.
    Shirwany A; Weber KT
    J Am Coll Cardiol; 2006 Jul; 48(1):97-8. PubMed ID: 16814654
    [No Abstract]   [Full Text] [Related]  

  • 16. [Genetic aspects of myocardial hypertrophy in hypertrophic cardiomyopathy and arterial hypertension].
    Smirnova MD; Fofanova TV; Postnov AIu; Ageev FT
    Ter Arkh; 2008; 80(1):77-84. PubMed ID: 18326235
    [No Abstract]   [Full Text] [Related]  

  • 17. Significance and relation between magnitude of left ventricular hypertrophy and heart failure symptoms in hypertrophic cardiomyopathy.
    Maron MS; Zenovich AG; Casey SA; Link MS; Udelson JE; Aeppli DM; Maron BJ
    Am J Cardiol; 2005 Jun; 95(11):1329-33. PubMed ID: 15904638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiating physiology from pathology in elite athletes. Left ventricular hypertrophy versus hypertrophic cardiomyopathy.
    Krysztofiak H; Petkow Dimitrow P
    Kardiol Pol; 2016; 74(8):705-716. PubMed ID: 27221963
    [No Abstract]   [Full Text] [Related]  

  • 19. [Echocardiographic study of myocardial masses in primary hypertrophic cardiomyopathy and in hypertensive cardiomyopathy].
    Mottironi P; Martinelli MM; Palagi L; Alcini E
    Minerva Cardioangiol; 1985 Mar; 33(3):97-103. PubMed ID: 4040225
    [No Abstract]   [Full Text] [Related]  

  • 20. Atorvastatin prevents connexin43 remodeling in hypertrophied left ventricular myocardium of spontaneously hypertensive rats.
    Chen HJ; Yao L; Chen TG; Yu M; Wang LH; Chen JZ
    Chin Med J (Engl); 2007 Nov; 120(21):1902-7. PubMed ID: 18067764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.